RadNet, Inc. (RDNT)
NASDAQ: RDNT · Real-Time Price · USD
68.41
+4.81 (7.56%)
At close: Aug 13, 2025, 4:00 PM
68.50
+0.09 (0.13%)
After-hours: Aug 13, 2025, 7:54 PM EDT
RadNet Market Cap
RadNet has a market cap or net worth of $5.26 billion as of August 13, 2025. Its market cap has increased by 14.93% in one year.
Market Cap
5.26B
Enterprise Value
6.27B
1-Year Change
14.93%
Ranking
Category
Stock Price
$68.41
Market Cap Chart
Since December 1, 1998, RadNet's market cap has increased from $4.50M to $5.26B, an increase of 116,829.51%. That is a compound annual growth rate of 30.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 4.77B | -7.76% |
Dec 31, 2024 | 5.17B | 119.00% |
Dec 29, 2023 | 2.36B | 118.56% |
Dec 30, 2022 | 1.08B | -32.87% |
Dec 31, 2021 | 1.61B | 59.23% |
Dec 31, 2020 | 1.01B | -0.98% |
Dec 31, 2019 | 1.02B | 105.33% |
Dec 31, 2018 | 497.00M | 3.33% |
Dec 29, 2017 | 481.00M | 60.49% |
Dec 30, 2016 | 299.70M | 5.16% |
Dec 31, 2015 | 285.00M | -21.85% |
Dec 31, 2014 | 364.70M | 445.14% |
Dec 31, 2013 | 66.90M | -31.03% |
Dec 31, 2012 | 97.00M | 21.71% |
Dec 30, 2011 | 79.70M | -23.59% |
Dec 31, 2010 | 104.30M | 41.33% |
Dec 31, 2009 | 73.80M | -38.45% |
Dec 31, 2008 | 119.90M | -66.04% |
Dec 31, 2007 | 353.10M | 262.15% |
Dec 29, 2006 | 97.50M | 770.54% |
Dec 30, 2005 | 11.20M | -48.62% |
Dec 31, 2004 | 21.80M | -5.22% |
Dec 31, 2003 | 23.00M | 30.68% |
Dec 31, 2002 | 17.60M | -68.23% |
Dec 31, 2001 | 55.40M | 357.85% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
AstraZeneca | 232.33B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |